FR2374319B1 - - Google Patents

Info

Publication number
FR2374319B1
FR2374319B1 FR7738319A FR7738319A FR2374319B1 FR 2374319 B1 FR2374319 B1 FR 2374319B1 FR 7738319 A FR7738319 A FR 7738319A FR 7738319 A FR7738319 A FR 7738319A FR 2374319 B1 FR2374319 B1 FR 2374319B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7738319A
Other languages
French (fr)
Other versions
FR2374319A1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Richardson Vicks Inc
Original Assignee
Richardson Merrell Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richardson Merrell Inc filed Critical Richardson Merrell Inc
Publication of FR2374319A1 publication Critical patent/FR2374319A1/en
Application granted granted Critical
Publication of FR2374319B1 publication Critical patent/FR2374319B1/fr
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/68Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/58One oxygen atom, e.g. butenolide
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30Hetero atoms other than halogen
    • C07D333/32Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Oncology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Furan Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
FR7738319A 1976-12-20 1977-12-19 SUBSTITUTE FURANNE- AND THIOPHENECARBALDEHYDES AND SUBSTITUTE FURYLALKYLCETONES AND SUBSTITUTE THIENYLALKYLCETONES, USE IN PARTICULAR AS ANTI-RHINOVIRUS AGENTS, AND THEIR PROCESS FOR PREPARATION Granted FR2374319A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US75113976A 1976-12-20 1976-12-20

Publications (2)

Publication Number Publication Date
FR2374319A1 FR2374319A1 (en) 1978-07-13
FR2374319B1 true FR2374319B1 (en) 1980-10-17

Family

ID=25020661

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7738319A Granted FR2374319A1 (en) 1976-12-20 1977-12-19 SUBSTITUTE FURANNE- AND THIOPHENECARBALDEHYDES AND SUBSTITUTE FURYLALKYLCETONES AND SUBSTITUTE THIENYLALKYLCETONES, USE IN PARTICULAR AS ANTI-RHINOVIRUS AGENTS, AND THEIR PROCESS FOR PREPARATION

Country Status (15)

Country Link
JP (1) JPS5377055A (en)
AU (1) AU512654B2 (en)
BE (1) BE862066A (en)
CA (1) CA1104574A (en)
DE (1) DE2755750A1 (en)
DK (1) DK564977A (en)
ES (1) ES465093A1 (en)
FR (1) FR2374319A1 (en)
GB (1) GB1539636A (en)
IE (1) IE45905B1 (en)
IL (1) IL53386A0 (en)
NL (1) NL7713825A (en)
NZ (1) NZ185688A (en)
SE (1) SE436878B (en)
ZA (1) ZA776821B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0213066U (en) * 1988-07-12 1990-01-26
AU621434B2 (en) * 1988-12-21 1992-03-12 Merrell Dow Pharmaceuticals Inc. Antiretroviral furan ketones
US4980371A (en) * 1988-12-21 1990-12-25 Merrell Dow Pharmaceuticals Antiretroviral furan ketones
US4977185A (en) * 1988-12-21 1990-12-11 Merrell Dow Pharmaceuticals Antiretroviral aryloxy substituted furan ketones

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2746973A (en) * 1955-05-27 1956-05-22 Du Pont 5-alkylmercapto-2-heterocyclic aldehydes and ketones
US4000164A (en) * 1973-04-02 1976-12-28 Richardson-Merrell Inc. Hypolipidemic agents

Also Published As

Publication number Publication date
AU3086777A (en) 1979-05-31
DE2755750A1 (en) 1978-06-22
NL7713825A (en) 1978-06-22
JPS622565B2 (en) 1987-01-20
BE862066A (en) 1978-04-14
CA1104574A (en) 1981-07-07
DK564977A (en) 1978-06-21
NZ185688A (en) 1980-09-12
IE45905L (en) 1978-06-20
SE436878B (en) 1985-01-28
AU512654B2 (en) 1980-10-23
ZA776821B (en) 1978-09-27
SE7714210L (en) 1978-06-21
FR2374319A1 (en) 1978-07-13
IL53386A0 (en) 1978-01-31
JPS5377055A (en) 1978-07-08
IE45905B1 (en) 1982-12-29
ES465093A1 (en) 1978-12-01
GB1539636A (en) 1979-01-31

Similar Documents

Publication Publication Date Title
FR2360493B1 (en)
FR2374319B1 (en)
JPS5371324U (en)
JPS52126291U (en)
JPS5421828Y2 (en)
JPS5527125B2 (en)
JPS5323529U (en)
IN154166B (en)
JPS5385838U (en)
JPS5340326U (en)
JPS53444U (en)
JPS5389315U (en)
JPS5379566U (en)
CH598892A5 (en)
DD126860A1 (en)
DD125450A1 (en)
DD124491A1 (en)
CH591876A5 (en)
CH597460A5 (en)
DD125142A1 (en)
BG23486A1 (en)
CH598768A5 (en)
CH598890A5 (en)
DD124444A1 (en)
BG23451A1 (en)

Legal Events

Date Code Title Description
ST Notification of lapse